Documentary The Real Peter Marks: April 16
April 16: Watch a LIVE Press Conference at the TheHighWire.com at 12pm PT (3pm ET). For the first time, we will reveal the secret recordings. After the press conference, return to TheRealPeterMarks.com to view the full timeline including exclusive video, private records, and internal communications with links to the complete files.
The timeline they never wanted you to see
ICAN, in partnership with React19 and Follow The Silenced, will release a virtual timeline of the COVID-19 vaccine rollout, exposing never-before-seen internal FDA records and exclusive video footage tied to the tenure of Dr. Peter Marks, the now-former Director of the FDA’s Center for Biologics Evaluation and Research (CBER). It was under Marks’ leadership that CBER authorized and subsequently approved the experimental mRNA COVID-19 vaccines.
After months of FOIA requests and legal work, the truth is finally coming to light. For the first time, view the vaccine rollout and safety monitoring from the perspective of both the FDA, the vaccine injured, and the broader public. What did the government know—and when? And once it learned certain things, did that affect what the public was being told?
The evidence suggests a disturbing pattern:
- Misleading public statements
- Gaslighting of vaccine-injured individuals
- Contradictory statements from Peter Marks
- A clear failure of accountability
Dr. Peter Marks Resigned From FDA
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented Associated Press
Years after helping drive the first Trump administration’s efforts to develop a Covid vaccine, Dr. Peter Marks resigned as the Food and Drug Administration’s leading official overseeing vaccines, citing his likely ouster while criticizing Health and Human Services Secretary Robert F. Kennedy’s views on vaccines and “misinformation and lies.”
“If [Marks] does not want to get behind restoring science to its gold standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy,” an HHS official told the Wall Street Journal (the HHS did not immediately respond to a request for comment).
What Did Dr. Peter Marks Say About Robert F. Kennedy Jr.?In his resignation letter, first obtained by the Journal, Marks said an HHS official forced him to choose between being fired or resigning. Marks wrote it had become “clear that truth and transparency are not desired” by Kennedy, who “wishes subservient confirmation of his misinformation and lies.” Marks, who noted he was previously willing to address Kennedy’s concerns about vaccine safety and transparency from the agency, said some claims about vaccines—including a debunked connection with autism—are “concerning.”
A recent outbreak of measles in several states underscores lowered confidence in “well-established vaccines” that have met the FDA’s standards for quality and safety, which could be “detrimental to public health and a clear danger to our nation’s health, safety and security,” Marks said.
Peter Marks Resigns From FDA As HHS Fires 10,000 Employees In Reorganization Effort 4/2/25
Dr. Peter Marks, an FDA official involved in Operation Warp Speed, has resigned from his position as director of the Center for Biologics Evaluation and Research (CBER). Marks started his career at the FDA as deputy director of the CBER in 2012 and has been the director since 2016. CBER is tasked with ensuring biological products, including vaccines, are safe and effective.
News outlets have reported that Dr. Marks was offered the option of resigning or being fired by HHS Secretary Robert F. Kennedy Jr. The Associated Press reports that the information came from a “former FDA official familiar with the discussions” who asked to remain anonymous. Kennedy has said one of his primary goals in running HHS is to root out conflicts of interest and the revolving door between regulators and the companies they are tasked to regulate.
Marks wrote a resignation letter criticizing Kennedy’s approach to public health. He wrote, “As you are aware, I was willing to work to address the Secretary’s concerns regarding vaccine safety and transparency by hearing from the public and implementing a variety of different public meetings and engagements with the National Academy of Sciences, Engineering, and Medicine. However, it has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies.”Multiple media outlets have reported that an HHS official released a statement saying that if Peter Marks “does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy.”
Dr. Vinay Prasad wrote a Substack post in response to Marks’ resignation and called him a “mediocre academic.” Prasad also wrote, “Peter Marks was one of the most dangerous, pro-pharma regulators of the 21st century. He is leaving and crafting a narrative that portrays him as a saint. That’s natural. But what is shocking is that the media is so uncritical, and not honest about his actions. The same media that lied about lab leak, masks, and all things covid is lying about Peter Marks.”
Prasad called out the media for lying about Kennedy pressuring Marks to resign without any specific action cited in their reports. Prasad criticized Marks for approving booster shots for 6-month-old children without any randomized data. The United States is still an outlier for the CDC’s recommendation that all healthy children as young as 6 months should get the COVID-19 vaccine despite low risk of mortality and severe outcomes from the virus.
Prasad also pointed out the obstacle the Biden administration faced when trying to mandate the COVID-19 vaccine for OSHA and military members. The vaccines were available via Emergency Use Authorization (EUA) rather than a biologic licensing agreement (BLA). There was some dispute about whether vaccines could be legally mandated with only an EUA.
Marks reportedly pressured Dr. Marion Gruber and Dr. Philip Krause to cut corners and approve the vaccine via BLA. When the two officials refused to bend to the pressure, Marks pressured them to resign. They resigned in 2021. Both Gruber and Krause stated this under oath to the House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust.
The press release from June 2024 concluded “The FDA succumbed to the Biden Administration’s pressure to act beyond its authority, which may have long-term impacts on the agency’s ability to confidently serve the American public. This poor policy by the Biden Administration reveals many significant problems related to accountability and good decision-making in the administrative state that warrant legislative reform.”
Dr. Gruber explained some of the tactics Dr. Peter Marks and Janet Woodcock used to pressure her to authorize the vaccine so the Biden administration could move forward with mandates. Gruber said, “They also made the point, as I state here in the email, that they feel that people have a tendency to get a vaccine that is authorized, but they may be hesitant and would be more likely to receive the vaccine if it would be licensed.”
Dr. Gruber also explained that the agency had data suggesting a risk of myocarditis, which requires a postmarketing study before the vaccines could be fully licensed. Gruber confirmed with Chairman Thomas Massie that Dr. Marks pressured her to “compress” this part of the timeline. When Gruber left her position in the FDA, Dr. Marks was appointed by Woodcock to replace her in this role.
When Massie asked Gruber if Dr. Marks and Woodcock had received instruction from outside the FDA to move up the timeline, Attorney Hilary LoCicero advised Gruber to not answer the question as it falls under the scope of a deliberative process within the FDA.Alongside Marks’ resignation are 10,000 job cuts within HHS that were recently announced. Secretary Kennedy posted on X in response to the job cuts. He wrote, “This is a difficult moment for all of us at HHS. Our hearts go out to those who have lost their jobs. But the reality is clear: what we’ve been doing isn’t working. Despite spending $1.9 trillion in annual costs, Americans are getting sicker every year. In the past four years alone, the agency’s budget has grown by 38% — yet outcomes continue to decline.
We must shift course. HHS needs to be recalibrated to emphasize prevention, not just sick care. These changes will not affect Medicare, Medicaid, or other essential health services. This overhaul is about realigning HHS with its core mission: to stop the chronic disease epidemic and Make America Healthy Again. It’s a win-win for taxpayers, and for every American we serve.”
Jeff Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases (NFID) said the current flu season is the “most severe” since 2017-2018.
The flu season peak typically ends in late February, with most people receiving their flu vaccinations in September or October, before the season officially begins. Medscape reported, “Many clinicians already discuss issues related to informed consent before administering any vaccines, Mazumder said.”
It is not possible to know how many clinicians provide informed consent before administering a vaccine, and it is not possible to know the specific details they provide.
Kennedy promised radical transparency as the HHS secretary, which involved presenting all of the science for the public to make informed decisions. It has not yet been reported if the “wild to mild” flu vaccine campaign will continue this season with a balanced description of the risks and benefits of taking the vaccine.
The Real Peter Marks – ICAN – Informed Consent Action Network
Documentary “Follow The Silenced” March 15
The Highwire Questions Peter Marks
The Highwire Episode 419: Question Marks
First, from pesticide lawsuits to mRNA vaccine bans, Jefferey Jaxen breaks down major health freedom battles across the U.S. and abroad; Aaron Siri, Esq. & React19’s Brianne Dressen expose new legal action against AstraZeneca; Filmmakers Mikki Willis & Matthew Guthrie reveal the truth behind Follow the Silenced.
EXCLUSIVE: Secret recordings of Dr. Peter Marks admitting vaccine harm behind closed doors.
PLUS: A shocking virtual timeline drops soon, featuring never-before-seen FDA docs and footage from the COVID-19 vaccine rollout.Visit: TheRealPeterMarks.com
Press conference + full timeline release: April 16, 2025
Guests: Brianne Dressen, Aaron Siri, Esq., Matt Guthrie, Mikki Willis
Making America Healthy Again (MAHA)
How We Can Make America Healthy Again shows that Americans spend an average of $12,555 per person on health care annually according to the Peterson-KFF Health Care Tracker. By comparison, typical health care spending across other developed nations is about $6,651,
However, Americans are the sickest, fattest, unhealthiest population. The US ranks high in infant mortality and ranks low in life expectancy compared to other industrialized nations. This shows that the American approach to healthcare is not working.
Robert Kennedy Jr. joined Trump’s Transition Team early last year, Trump’s Plan To Make America Healthy Again (MAHA) explains that Trump has nominated Kennedy to head the Department of Health and Human Services (HHS). Trump nominated Dr. Marty Makary to head the FDA. Trump picks Dr. Marty Makary as Food and Drug Administration commissioner: Trump said Makary would work under HHS nominee RFK Jr. to address the childhood chronic disease epidemic. Trump nominated Dr. Jay Bhattacharya as Director of the National Institutes of Health (NIH).
The Senate confirmed the nominations of RFK Jr. Dr. Bhattacharya, and Dr. Makary.
RFK Jr. Confirmed As HHS Secretary
RFK Jr.’s First Steps as Secretary of HHS
Dr. Jay Bhattacharya Confirmed As NIH Director
Senate confirms Marty Makary to lead FDA, Jay Bhattacharya to head NIH
RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign
February 28, 2025
HHS Secretary Robert F. Kennedy Jr. paused a clinical trial funded by the Biomedical Advanced Research and Development Authority (BARDA) for a COVID-19 oral vaccine made by Vaxart. Kennedy said, “While it is crucial that the Department [of] Health and Human Services (HHS) support pandemic preparedness, four years of the Biden administration’s failed oversight have made it necessary to review agreements for vaccine production, including Vaxart’s. I look forward to working with Vaxart and medical experts to ensure this work produces safe, effective, and fiscal-minded vaccine technology.”
There is currently a 90-day pause on the trial that was set to begin on Monday with 10,000 clinical trial participants. The oral vaccine would be evaluated against the existing mRNA COVID-19 vaccines currently available under Emergency Use Authorization (EUA).
Kennedy was named the chair of the new Make America Health Again (MAHA) commission, created by an executive order signed by President Donald Trump just after Kennedy was confirmed as HHS secretary.
The executive order states, “It shall be the policy of the Federal Government to aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases. To do so, executive departments and agencies (agencies) that address health or healthcare must focus on reversing chronic disease.”
The commission will work to provide transparent “open-source” data to the American people. This includes funding “gold-standard” research through the NIH and ensuring that the “United States food is the healthiest, most abundant, and most affordable in the world.”In October, Kennedy said “If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags.” According to recent reports, firings have begun within HHS.
Earlier this week, the conflict of interest discussion ramped up when Patrizia Cavazzoni was hired as chief medical officer for Pfizer about a month after leaving her position with the FDA. She joined the FDA in 2018 and became the director of the FDA’s Center for Drug Evaluation and Research (CDER) in 2021. She resigned from the position in January, shortly before Donald Trump was sworn in as the 47th president of the United States.
The Pfizer press release states, “Before joining CDER, Dr. Cavazzoni held several senior executive positions in the pharmaceutical industry for nearly two decades, including at Pfizer, Eli Lilly, and Sanofi. During her prior tenure at Pfizer, Dr. Cavazzoni led clinical sciences and development operations for the company across multiple senior roles.”
Pfizer received full EUA approval for its COVID-19 vaccine in August 2021 while Cavazzoni was the director of CDER within the FDA. The Daily Mail reported that Cavazzoni’s new role with Pfizer could pay up to $500,000 per year before bonuses, according to job posting sites.
Kennedy has promised to root out conflicts of interest, and the latest move by Cavazzoni reflects the ongoing revolving door between big pharmaceutical companies and federal health agencies.
During Kennedy’s address to HHS staff, he said, “I’m not going to come in here and impose my belief over any of yours. Instead, we’re going to work together to launch a new era of radical transparency. We will convene representatives of all viewpoints to study the causes for the drastic rise in chronic disease. Some of the possible factors we will investigate were formerly taboo or insufficiently scrutinized: the childhood vaccine schedule, electromagnetic radiation, glyphosate, other pesticides, ultra-processed foods, artificial food additives, SSRIs and other psychiatric drugs, PFAS, PFOAs, microplastics—nothing is going to be off limits. Whatever belief or suspicion I have expressed in the past, I’m willing to subject them all to the scrutiny of unbiased science.”
Kennedy also halted the CDC’s “wild to mild” flu vaccination marketing program that has been running since 2023. Reports say Kennedy wants future vaccine ads to focus on “informed consent.” In this case, the ads would mention the risks and benefits of getting the flu vaccine.
Yesterday on The HighWire, Jefferey Jaxen reported on the halt to the flu vaccination campaign. He presented a 2012 study that shows risks associated with flu vaccinations that could potentially be mentioned in future ads if they focus on informed consent. A randomized placebo study with 115 children found those who received the trivalent inactivated influenza vaccine were 440% more likely to be infected with “virologically-confirmed non-influenza” or upper respiratory infections.
The flu vaccination ad program attempted to show the public that flu vaccinations can prevent severe outcomes from infection and don’t necessarily prevent transmission. The ads did not provide the information that the vaccines can increase the likelihood of infection with other non-flu illnesses. Running ads that focus on informed consent could include both of these messages so individuals can make an informed decision with their doctors.
Shirin A. Mazumder, MD, an infectious disease expert in Memphis, Tennessee, said, “A shift in the messaging away from the benefit of vaccines has the potential to affect public perception and lead to an increase in vaccine-preventable illnesses and deaths in a population where vaccine uptake for flu and other respiratory viruses is already low.”
For More Information
Deception: The Great Covid Cover-Up
Shocking New Book: The Pfizer Papers
Trump Establishes MAHA Commission
Parents: Measles Didn’t Kill Girl In Texas
Shocking Documentary: “Thank You Dr. Fauci”
Pardoning Fauci Would Be Disservice to Him and Americans
Florida Hints at Legal Action Against Fauci for Pandemic Response
Hearing Wrap Up: Dr. Fauci Held Publicly Accountable by Select Subcommittee
The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health
A Plague Upon Our House: My Fight at the Trump White House to Stop COVID from Destroying America
FINAL REPORT: COVID Select Concludes 2-Year Investigation, Issues 500+ Page Final Report on Lessons Learned and the Path Forward
